COMP Price Prediction Next Week
Technical Analysis
Recent price action shows COMP trading at $9.01, down 4.66% in the latest session . The stock has formed a bearish reversal pattern after reaching a local high of $9.74.
Key Technical Levels
- Fibonacci levels indicate:
- Resistance: $9.95 (R1), $10.61 (R2)
- Support: $7.80 (S1), $7.14 (S2)
- Moving averages show bullish trend:
- SMA 5: $9.16
- SMA 20: $8.17
- SMA 200: $5.64
Momentum Indicators
- RSI (14) at 61.61 indicates neutral momentum
- MACD shows positive trend with value at 0.67
- Stochastic RSI suggests potential pullback with K(14) at 67.21
News Analysis
Recent positive catalysts:
- Barclays raised price target to $9 from $7
- Strong Q4 earnings with revenue up 25.9% to $1.38 billion
- Market share improved to 5.06%, highest year-over-year increase in three years
Price Prediction (Next Week)
Based on technical analysis and recent news:
- Bearish scenario (60% probability): Drop to $8.17 (20-day SMA)
- Neutral scenario (30% probability): Consolidation between $8.80-$9.20
- Bullish scenario (10% probability): Rebound to $9.95 (R1)
Recommendation: SELL
- Current price shows weakness after hitting resistance
- Technical indicators suggest downward pressure
- Take profit target: $8.17
- Stop loss: $9.74 (recent high)
COMP Similar Chart Price Prediction
The price of COMP is predicted to go up -11.76%, based on the high correlation periods with HTLD. The similarity of these two price pattern on the periods is 98.38%.
COMP
HTLD
Down: -11.76%Similarity: 98.38%
COMP Revenue Forecast
COMP EPS Forecast
COMP FAQs
What is bull’s view on COMP?
What is bear's view on COMP?
What is COMP revenue forecast for next quarter？
COMP Analyst's Forecast
Brian Nowak
Morgan Stanley
Hold
2025-02-19
Price Target
$6 → $8.5
Downside
-16.99%
Morgan Stanley analyst Matthew Cost raised the firm's price target on Compass to $8.50 from $6 and keeps an Equal Weight rating on the shares. Q4 results and guidance showed "strong execution against a tough housing backdrop" and private inventory initiatives could be a key share gain opportunity from here, the analyst tells investors in a post-earnings note.
Jason Helfstein
Oppenheimer
Buy
2025-02-19
Price Target
$12 → $13
Upside
+26.95%
Lloyd Walmsley
UBS
Strong Buy
2025-02-19
Price Target
$11 → $12
Upside
+17.19%
